Antiemetic care for patients with breast cancer: focus on drug interactions and safety concerns.
about
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroRandomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy.Effect of the Botanical Compound LCS101 on Chemotherapy-Induced Symptoms in Patients with Breast Cancer: A Case Series ReportDo drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting.
P2860
Antiemetic care for patients with breast cancer: focus on drug interactions and safety concerns.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antiemetic care for patients w ...... eractions and safety concerns.
@en
type
label
Antiemetic care for patients w ...... eractions and safety concerns.
@en
prefLabel
Antiemetic care for patients w ...... eractions and safety concerns.
@en
P2093
P356
P1476
Antiemetic care for patients w ...... eractions and safety concerns.
@en
P2093
Angela Georgy
Jacalyn Neceskas
Susan Goodin
P304
P356
10.2146/AJHP060609
P577
2007-11-01T00:00:00Z